| Bioactivity | Lexipafant is a platelet-activating factor (PAF) antagonist that inhibits the inflammatory response and is used in the treatment of acute pancreatitis. |
| Name | Lexipafant |
| CAS | 139133-26-9 |
| Formula | C23H30N4O4S |
| Molar Mass | 458.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kingsnorth AN, Galloway SW, Formela LJ. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg. 1995;82(10):1414-1420. [2]. Galloway SW, Kingsnorth AN. Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist. Pancreas. 1996;13(2):140-146. |
Lexipafant
CAS: 139133-26-9 F: C23H30N4O4S W: 458.57
Lexipafant is a platelet-activating factor (PAF) antagonist that inhibits the inflammatory response and is used in the t
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.